Frances Stocks AllenAssociate at Latham & Watkins LLP, UK
Frances Stocks Allen is a life sciences associate in the firm's London office. Ms. Stocks Allen practices in the firm’s Corporate Department, focusing primarily on transactional, licensing, intellectual property, and regulatory matters.
Ms. Stocks Allen advises on a broad spectrum of licensing and other complex commercial and intellectual property arrangements including licensing, distribution, supply, and complex corporate separation and divestment in the life sciences sector. Ms. Stocks Allen also has expertise in EU and UK regulatory issues and data privacy, including the General Data Protection Regulation (GDPR).
In 2017, Ms. Stocks Allen was seconded to the firm's Silicon Valley office to work on cutting-edge biotechnology and licensing matters in the life sciences sector. In 2015, Ms. Stocks Allen was seconded in-house to Allergan, where she worked as part of the global commercial team, advising on licensing and other commercial arrangements, and assisting with the implementation of its US$66 billion acquisition by Actavis.
Ms. Stocks Allen is a Committee member of Women in Law London (WILL), an active professional network with approximately 2,000 members, promoting the advancement of women solicitors.